Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open multicenter phase 2 trial of intradermal polymerized Dermatophagoides pteronyssinus allergoid
2014-004429-42Phase 2Completed
- Sponsor
- Laboratorios Diater
- Start
- Dec 2014
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of polymerized Dermatophagoides pteronyssinus allergoid in allergic rhinoconjunctivitis (ARC), asthma and house dust mite allergy, sponsored by Laboratorios Diater. Primary endpoint: Maximum wheal diameter. Started Dec 2014; status: completed.
02
Drugs
polymerized Dermatophagoides pteronyssinus allergoid
03
Conditions
allergic rhinoconjunctivitis (ARC)asthmahouse dust mite allergy
Beyond the preview
Go deeper on 2014-004429-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004429-42.